Influence of parotid-sparing radiotherapy on xerostomia in head and neck cancer patients

Silverman, 1999, Oral cancer: complications of therapy, Oral Surg Oral Med Oral Pathol Oral Radiol Endo, 88, 122, 10.1016/S1079-2104(99)70103-4 Scully, 1996, Oral health care for the cancer patient, Oral Oncol, 32B, 281, 10.1016/0964-1955(96)00037-1 Valdez, 1993, Major salivary gland function in patients with radiation-induced xerostomia: flow rates and sialochemistry, Int J Rad Oncol Biol Phys, 25, 41, 10.1016/0360-3016(93)90143-J August M, Wang J, Plante D, Wang CC. Complications associated with therapeutic neck radiation. J Oral Maxillofac Surg 1996;54(12):1409–15; discussion 1415–6. Pauloski, 1998, Speech and swallowing in irradiated and nonirradiated postsurgical oral cancer patients, Otolaryngol Head Neck Surg, 118, 616 Eisbruch, 1999, Conformal and intensity modulated irradiation of head and neck cancer: the potential for improved target irradiation, salivary gland function, and quality of life, Acta Oto Rhino Laryng Belg, 53, 271 Eisbruch, 1999, Dose, volume, and function relationships in parotid salivary glands following conformal and intensity modulated irradiation of head and neck cancer, Int J Rad Oncol Biol Phys, 45, 577, 10.1016/S0360-3016(99)00247-3 Eisbruch, 1996, Parotid gland sparing in patients undergoing bilateral head and neck irradiation: techniques and early results, Int J Rad Oncol Biol Phys, 36, 469, 10.1016/S0360-3016(96)00264-7 Hazuka, 1993, Preservation of parotid function after external beam irradiation in head and neck cancer patients: a feasibility study using 3-dimensional treatment planning, Int J Rad Oncol Biol Phys, 27, 731, 10.1016/0360-3016(93)90403-I Henson, 1999, Two-year longitudinal study of parotid salivary flow rates in head and neck cancer patients receiving unilateral neck parotid-sparing radiotherapy treatment, Oral Oncol, 35, 234, 10.1016/S1368-8375(98)00104-3 Dawson, 2000, Patterns of local–regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer, Int J Rad Oncol Biol Phys, 46, 1117, 10.1016/S0360-3016(99)00550-7 Epstein, 1999, Quality of life and oral function following radiotherapy for head and neck cancer, Head Neck, 21, 1, 10.1002/(SICI)1097-0347(199901)21:1<1::AID-HED1>3.0.CO;2-4 Bjordal, 1994, Quality of life in patients treated for head and neck cancer: a follow-up study 7 to 11 years after radiotherapy, Int J Rad Oncol Biol Phys, 28, 847, 10.1016/0360-3016(94)90104-X Greenlee, 2000, Cancer statistics, 2000, Cancer J Clin, 50, 7, 10.3322/canjclin.50.1.7 Mor, 1984, The Karnofsky performance status scale. An examination of its reliability and validity in a research setting, Cancer, 53, 2002, 10.1002/1097-0142(19840501)53:9<2002::AID-CNCR2820530933>3.0.CO;2-W Jones, 1996, Ipsilateral parotid sparing study in head and neck cancer patients receiving radiation therapy: 1 year results, Oral Surg Oral Med Oral Pathol Oral Radiol Endo, 81, 642, 10.1016/S1079-2104(96)80068-0 Ship, 1997, Parotid sparing study in head and neck cancer patients receiving bilateral radiation therapy: 1 year results, J Dent Res, 76, 807, 10.1177/00220345970760031401 Ang KK, Kaanders JH, Peters LJ. Radiotherapy for head and neck cancers: indications and techniques. Philadelphia: Lea & Fabiger; 1994. Million RR, Cassisi NJ. Management of head and neck cancer, 2nd ed. Philadelphia: J.B. Lippincott Co.; 1994. Eisbruch, 1998, Comprehensive irradiation of head and neck cancer using conformal multisegmental fields: assessment of target coverage and noninvolved tissue sparing, Int J Rad Oncol Biol Phys, 41, 559, 10.1016/S0360-3016(98)00082-0 Baum, 1981, Characteristics of participants in the oral physiology component of the Baltimore longitudinal study of aging, Comm Dent Oral Epidemiol, 9, 128, 10.1111/j.1600-0528.1981.tb01043.x Heft, 1984, Unstimulated and stimulated parotid salivary flow rate in individuals of different ages, J Dent Res, 63, 1182, 10.1177/00220345840630100101 Ship, 1991, Normal salivary gland function: how much saliva is enough?, J Am Dent Assoc, 122, 63, 10.14219/jada.archive.1991.0098 Dawes, 1972, Circadian rhythms in human salivary flow rate and composition, J Physiol, 220, 529, 10.1113/jphysiol.1972.sp009721 Fox, 1987, Subjective reports of xerostomia and objective measures of salivary gland performance, J Am Dent Assoc, 115, 581, 10.1016/S0002-8177(87)54012-0 Cleophas TJ, Zwinderman AH, Cleophas TF. Statistics applied to clinical trials, 2nd ed. Dordrecht, The Netherlands: Kluwer Academic Publishers; 2002. SOMA. LENT SOMA tables. Radiother Oncol 1995;35(1):17–60. Pavy, 1995, EORTC Late Effects Working Group. Late effects toxicity scoring: the SOMA scale, Radiother Oncol, 35, 11, 10.1016/0167-8140(95)97448-M Henson, 2001, Preserved salivary output and xerostomia-related quality of life in head and neck cancer patients receiving parotid-sparing radiotherapy, Oral Oncol, 37, 84, 10.1016/S1368-8375(00)00063-4 Sonis, 1999, Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group, Cancer, 85, 2103, 10.1002/(SICI)1097-0142(19990515)85:10<2103::AID-CNCR2>3.0.CO;2-0 Harrison, 1997, Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue, Head Neck, 19, 169, 10.1002/(SICI)1097-0347(199705)19:3<169::AID-HED1>3.0.CO;2-0 Epstein, 1994, A clinical trial of bethanechol in patients with xerostomia after radiation therapy. A pilot study, Oral Surg Oral Med Oral Pathol, 77, 610, 10.1016/0030-4220(94)90320-4 Davies, 1994, A comparison of artificial saliva and pilocarpine in radiation-induced xerostomia, J Laryngol Otol, 108, 663, 10.1017/S0022215100127768 Hamada, 1999, Treatment of xerostomia with the bile secretion-stimulating drug anethole trithione: a clinical trial, Am J Med Sci, 318, 146, 10.1097/00000441-199909000-00009 Hamlar, 1996, Determination of the efficacy of topical oral pilocarpine for postirradiation xerostomia in patients with head and neck carcinoma, Laryngoscope, 106, 972, 10.1097/00005537-199608000-00011 Jacobs, 1996, A multicenter maintenance study of oral pilocarpine tablets for radiation-induced xerostomia, Oncology, 10, 16 Johnson, 1993, Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer, N Engl J Med, 329, 390, 10.1056/NEJM199308053290603 LeVeque, 1993, A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients, J Clin Oncol, 11, 1124, 10.1200/JCO.1993.11.6.1124 Greenspan, 1990, Oral complications of cancer therapies. Management of salivary dysfunction, NCI Monogr, 9, 159 Niedermeier, 1998, Radiation-induced hyposalivation and its treatment with oral pilocarpine, Oral Surg Oral Med Oral Pathol Oral Radiol Endo, 86, 541, 10.1016/S1079-2104(98)90343-2 Zimmerman, 1997, Concomitant pilocarpine during head and neck irradiation is associated with decreased posttreatment xerostomia, Int J Rad Oncol Biol Phys, 37, 571, 10.1016/S0360-3016(96)00557-3 Baum, 1999, In vivo gene transfer to salivary glands, Crit Rev Oral Biol Med, 10, 276, 10.1177/10454411990100030201 Baum, 1995, The impact of gene therapy on dentistry, J Am Dent Assoc, 126, 179, 10.14219/jada.archive.1995.0143 O’Connell, 1999, Safety and efficacy of adenovirus-mediated transfer of the human aquaporin-1 cDNA to irradiated parotid glands of non-human primates, Cancer Gene Therapy, 6, 505, 10.1038/sj.cgt.7700078 Mastrangeli, 1994, Direct in vivo adenovirus-mediated gene transfer to salivary glands, Am J Physiol, 266, G1146